Elizabeth Hibler, PhD

Bio

Dr. Hibler’s lab is studying the biological links between behavior and breast cancer risk with the goal of using biological signatures to improve precision prevention programs among high-risk individuals. She is studying modifiable risk factors, such as physical activity and diet, and molecular biomarkers of primary and secondary prevention of breast cancer. She has evaluated the impact of diet and behavior interventions on circulating levels of inflammation and patterns of DNA methylation among both healthy adults and women at high risk for cancer.

 

Dr. Hibler started as an Assistant Professor in the Northwestern University Feinberg School of Medicine in 2016. Her prior training included an MPH in health policy with a focus on epidemiology from the University of Michigan and a PhD in epidemiology with a minor in cancer biology from the University of Arizona. She then completed postdoctoral training in Cancer Prevention and Control at the University of Arizona Cancer Center and Molecular and Genetic Epidemiology of Cancer at Vanderbilt University. These unique training opportunities focused on laboratory-based molecular techniques, while expanding her skills in epidemiologic research to incorporate -omics biomarkers into population studies.

Dr. Hibler is investigating associations between device-based measures of physical activity and DNA methylation by breast density status. High breast density is a recognized risk factor because it can mask breast cancer tumors on routine mammograms. However, it is not yet clear if the differences in high versus normal density breast tissue may also be related to changes in molecular signatures.

Elizabeth Hibler, PhD

Northwestern University Feinberg School of Medicine

News & Articles

3 Chicago Hospitals Team Up to Fight Breast Cancer in New Clinical Trial

Top Chicago Hospitals Join Forces in the Chicago Breast Cancer Research Consortium

Three Chicago Hospitals Collaborate on Breast Cancer Clinical Trial

Meet Our Other Scholars

Abde Abukhdeir, PhD headshot v2

Past

Early Investigator

Abde Abukhdeir, PhD

Dr. Nan Chen

Past

Early Investigator

Nan Chen, MD

Discovering Novel Biomarkers of Therapy Response and Resistance in Metastatic Triple-Negative Breast Cancer Patients

Peiwen Chen, PhD headshot

Past

Early Investigator

Peiwen Chen, PhD

Targeting Macrophage Reprogramming in Brain Metastatic Breast Cancer

Why your gift matters

Every scholar funded is a future breakthrough made possible

Your gift helps researchers test bold ideas, generate critical data, and take the first steps toward the next major advancement in breast cancer treatment and care.Together, we can accelerate discoveries that save lives.

Contact Us

Email info@lynnsage.org
Contact Form (#6)